Ligand Pharmaceuticals Inc
LGND· Nasdaq
LGNDLigand Pharmaceuticals Inc
Source filing unavailable
| Metric | Q1 2011 | Q1 2010 |
|---|---|---|
| Revenue | $5.64M | $3.90M |
| Net Income | $1.13M | $9.63M |
| EPS Diluted | $0.06 | $0.49 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ligand Pharmaceuticals Inc · CIK 886163 · Engraved from SEC EDGAR
